CX3CR1 and familial dilated cardiomyopathy: Here, we evaluate whether therapeutic modulation of CX3CR1 can provide neuroprotection and improve neurological outcomes in a mouse model of DCM, and we corroborate these findings using human postmortem spinal cord tissue.